Hoang C Dang
Examiner (ID: 12651)
Most Active Art Unit | 3506 |
Art Unit(s) | 3506, 2731, 3625, 3672 |
Total Applications | 3000 |
Issued Applications | 2548 |
Pending Applications | 156 |
Abandoned Applications | 295 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16930905
[patent_doc_number] => 20210196794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => FGF21 VARIANT, FUSION PROTEIN AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/960254
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960254
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960254 | FGF21 variant, fusion protein and application thereof | Jan 28, 2019 | Issued |
Array
(
[id] => 16125997
[patent_doc_number] => 10696740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Methods of treating ocular diseases
[patent_app_type] => utility
[patent_app_number] => 16/254173
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19062
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/254173 | Methods of treating ocular diseases | Jan 21, 2019 | Issued |
Array
(
[id] => 14581353
[patent_doc_number] => 20190218285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Long-Acting Therapeutic Fusion Proteins
[patent_app_type] => utility
[patent_app_number] => 16/252030
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/252030 | Long-Acting Therapeutic Fusion Proteins | Jan 17, 2019 | Abandoned |
Array
(
[id] => 14230521
[patent_doc_number] => 20190127433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => GLUCAGON/GLP-1 RECEPTOR CO-AGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/241932
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241932 | Glucagon/GLP-1 receptor co-agonists | Jan 6, 2019 | Issued |
Array
(
[id] => 16613948
[patent_doc_number] => 20210032601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHOD OF INCREASING PROLIFERATION OF PANCREATIC BETA CELLS, TREATMENT METHOD, AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/959390
[patent_app_country] => US
[patent_app_date] => 2019-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959390 | Method of increasing proliferation of pancreatic beta cells, treatment method, and composition | Jan 4, 2019 | Issued |
Array
(
[id] => 16613948
[patent_doc_number] => 20210032601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHOD OF INCREASING PROLIFERATION OF PANCREATIC BETA CELLS, TREATMENT METHOD, AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/959390
[patent_app_country] => US
[patent_app_date] => 2019-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959390 | Method of increasing proliferation of pancreatic beta cells, treatment method, and composition | Jan 4, 2019 | Issued |
Array
(
[id] => 16613948
[patent_doc_number] => 20210032601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHOD OF INCREASING PROLIFERATION OF PANCREATIC BETA CELLS, TREATMENT METHOD, AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/959390
[patent_app_country] => US
[patent_app_date] => 2019-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959390 | Method of increasing proliferation of pancreatic beta cells, treatment method, and composition | Jan 4, 2019 | Issued |
Array
(
[id] => 16613948
[patent_doc_number] => 20210032601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHOD OF INCREASING PROLIFERATION OF PANCREATIC BETA CELLS, TREATMENT METHOD, AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/959390
[patent_app_country] => US
[patent_app_date] => 2019-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959390 | Method of increasing proliferation of pancreatic beta cells, treatment method, and composition | Jan 4, 2019 | Issued |
Array
(
[id] => 16569164
[patent_doc_number] => 20210008170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => TREATMENT OF EXERCISE-INDUCED HYPOGLYCEMIA IN TYPE 1 AND INSULIN USING TYPE 2 DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/955698
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955698 | TREATMENT OF EXERCISE-INDUCED HYPOGLYCEMIA IN TYPE 1 AND INSULIN USING TYPE 2 DIABETES | Dec 20, 2018 | Abandoned |
Array
(
[id] => 14833431
[patent_doc_number] => 20190275116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND METHODS FOR FABRICATION OF SOLID MASSES COMPRISING GLUCOSE REGULATING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/229711
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229711
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229711 | Shaped mass composition comprising exenatide | Dec 20, 2018 | Issued |
Array
(
[id] => 17974398
[patent_doc_number] => 11491235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Oral gene carrier and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/956779
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10127
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956779
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956779 | Oral gene carrier and use thereof | Dec 19, 2018 | Issued |
Array
(
[id] => 14185287
[patent_doc_number] => 20190112348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 16/220414
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 319
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220414 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14160855
[patent_doc_number] => 20190107530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => METHOD OF DETECTION OF CLINICALLY SIGNIFICANT POST-PRANDIAL HYPERGLYCEMIA IN NORMOGLYCEMIC PATIENTS
[patent_app_type] => utility
[patent_app_number] => 16/212356
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212356 | METHOD OF DETECTION OF CLINICALLY SIGNIFICANT POST-PRANDIAL HYPERGLYCEMIA IN NORMOGLYCEMIC PATIENTS | Dec 5, 2018 | Abandoned |
Array
(
[id] => 18216458
[patent_doc_number] => 11591380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Glucagon-like peptides
[patent_app_type] => utility
[patent_app_number] => 16/769774
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 56
[patent_no_of_words] => 15397
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769774 | Glucagon-like peptides | Dec 3, 2018 | Issued |
Array
(
[id] => 14072313
[patent_doc_number] => 20190085044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => NOVEL THIOAMIDE-MODIFIED PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/209128
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16209128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/209128 | Method of stabilizing a bioactive peptide against protease hydrolysis | Dec 3, 2018 | Issued |
Array
(
[id] => 16883838
[patent_doc_number] => 20210170033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/768600
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768600
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768600 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | Nov 29, 2018 | Abandoned |
Array
(
[id] => 14069383
[patent_doc_number] => 20190083579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => COMPOSITION FOR TREATING DIABETES COMPRISING LONG-ACTING INSULIN CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 16/206365
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16206365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/206365 | COMPOSITION FOR TREATING DIABETES COMPRISING LONG-ACTING INSULIN CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | Nov 29, 2018 | Abandoned |
Array
(
[id] => 16688353
[patent_doc_number] => 20210070829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => MULTI-DOMAIN ACTIVE PROTEIN FOR TREATING METABOLIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/762942
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762942 | Multi-domain active protein for treating metabolic diseases | Nov 18, 2018 | Issued |
Array
(
[id] => 16883791
[patent_doc_number] => 20210169986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => GLP-2 ANALOGS AND PEPTIBODIES FOR ADMINISTRATION BEFORE, DURING OR AFTER SURGERY
[patent_app_type] => utility
[patent_app_number] => 16/761606
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761606 | GLP-2 analogs and peptibodies for administration before, during or after surgery | Nov 4, 2018 | Issued |
Array
(
[id] => 17028564
[patent_doc_number] => 11090362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Pharmaceutical composition comprising IL-34 and a mTOR inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/174837
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20367
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/174837 | Pharmaceutical composition comprising IL-34 and a mTOR inhibitor | Oct 29, 2018 | Issued |